Literature DB >> 26430235

Budesonide-related adrenal insufficiency.

Alexander Arntzenius1, Louise van Galen2.   

Abstract

Iatrogenic adrenal insufficiency is a potential harmful side effect of treatment with corticosteroids. It manifests itself when an insufficient cortisol response to biological stress leads to an Addisonian crisis: a life-threatening situation. We describe a case of a patient who developed an Addisonian crisis after inappropriate discontinuation of budesonide (a topical steroid used in Crohn's disease) treatment. Iatrogenic adrenal insufficiency due to budesonide use has been rarely reported. Prescribers should be aware of the resulting risk for an Addisonian crisis. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26430235      PMCID: PMC4600789          DOI: 10.1136/bcr-2015-212216

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

1.  Severe adrenal insufficiency complicating budesonide therapy for Crohn's disease.

Authors:  Charles Berkelhammer; Mais Trabolsi; Jelena Andrejic; Tahira Yasmeen
Journal:  Inflamm Bowel Dis       Date:  2011-04       Impact factor: 5.325

Review 2.  Adrenocortical insufficiency.

Authors:  C W Burke
Journal:  Clin Endocrinol Metab       Date:  1985-11

3.  Management of Crohn's disease in adults.

Authors:  Gary R Lichtenstein; Stephen B Hanauer; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2009-01-06       Impact factor: 10.864

4.  Oral budesonide for maintenance of remission of Crohn's disease: a pooled safety analysis.

Authors:  G R Lichtenstein; B Bengtsson; L Hapten-White; P Rutgeerts
Journal:  Aliment Pharmacol Ther       Date:  2008-11-13       Impact factor: 8.171

  4 in total
  3 in total

1.  Evidence of Systemic Absorption of Enteral Budesonide in Patients with Fontan-Associated Protein-Losing Enteropathy.

Authors:  Richard Ogden Roberts; Michael V Di Maria; Dania Brigham; Stephanie Hsu
Journal:  Pediatr Cardiol       Date:  2019-11-09       Impact factor: 1.655

2.  Tranexamic Acid and Supportive Measures to Treat Wasting Marmoset Syndrome.

Authors:  Takuro Yoshimoto; Kimie Niimi; Eiki Takahashi
Journal:  Comp Med       Date:  2016-12-01       Impact factor: 0.982

3.  Mining drug-target and drug-adverse drug reaction databases to identify target-adverse drug reaction relationships.

Authors:  Cristiano Galletti; Patricia Mirela Bota; Baldo Oliva; Narcis Fernandez-Fuentes
Journal:  Database (Oxford)       Date:  2021-10-20       Impact factor: 3.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.